Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Octreotide LA by Camurus for Neuroendocrine Tumors: Likelihood of Approval
Octreotide LA is under clinical development by Camurus and currently in Phase III for Neuroendocrine Tumors. According to GlobalData, Phase...
Data Insights
Octreotide LA by Camurus for Neuroendocrine Tumors: Likelihood of Approval
Octreotide LA is under clinical development by Camurus and currently in Phase III for Neuroendocrine Tumors. According to GlobalData, Phase...